Jana Jiravova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jana Jiravova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Katerina Tomankova
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hněvotínská 976/3, 779 00 Olomouc, Czech Republic
5 shared publications - Lukáš Malina
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc
5 shared publications Hana Kolarova
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech Republic
3 shared publications- Hana Kolarova
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech Republic
2 shared publications Jakub Malohlava
Department of Medical Biophysics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic
2 shared publications- Jakub Malohlava
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Institute of Translational Medicine, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic
2 shared publications
Latest Publications
- Open Access
Size-Selected Graphene Oxide Loaded with Photosensitizer (TMPyP) for Targeting Photodynamic Therapy In Vitro
Targeted therapies of various diseases are nowadays widely studied in many biomedical fields. Photodynamic therapy (PDT) represents a modern treatment of cancer using a locally activated light. TMPyP is an efficient synthetic water-soluble photosensitizer (PS), yet with poor absorption in the visible and the red regions. In this work, we prepared size-selected and colloidally stable graphene oxide (GO) that is appropriate for biomedical use. Thanks to the negative surface charge of GO, TMPyP was easily linked in order to create conjugates of GO/TMPyP by electrostatic force. Due to the strong ionic interactions, charge transfers between GO and TMPyP occur, as comprehensively investigated by steady-state and time-resolved fluorescence spectroscopy. Biocompatibility and an in vitro effect of GO/TMPyP were confirmed by a battery of in vitro tests including MTT, comet assay, reactive oxygen species (ROS) production, and monitoring the cellular uptake. PDT efficiency of GO/TMPyP was tested using 414 and 740 nm photoexcitation. Our newly prepared nanotherapeutics showed a higher PDT effect than in free TMPyP, and is promising for targeted therapy using clinically favorable conditions.
Open AccessSize-Selected Graphene Oxide Loaded with Photosensitizer (TMPyP) for Targeting Photodynamic Therapy In Vitro
Targeted therapies of various diseases are nowadays widely studied in many biomedical fields. Photodynamic therapy (PDT) represents a modern treatment of cancer using a locally activated light. TMPyP is an efficient synthetic water-soluble photosensitizer (PS), yet with poor absorption in the visible and the red regions. In this work, we prepared size-selected and colloidally stable graphene oxide (GO) that is appropriate for biomedical use. Thanks to the negative surface charge of GO, TMPyP was easily linked in order to create conjugates of GO/TMPyP by electrostatic force. Due to the strong ionic interactions, charge transfers between GO and TMPyP occur, as comprehensively investigated by steady-state and time-resolved fluorescence spectroscopy. Biocompatibility and an in vitro effect of GO/TMPyP were confirmed by a battery of in vitro tests including MTT, comet assay, reactive oxygen species (ROS) production, and monitoring the cellular uptake. PDT efficiency of GO/TMPyP was tested using 414 and 740 nm photoexcitation. Our newly prepared nanotherapeutics showed a higher PDT effect than in free TMPyP, and is promising for targeted therapy using clinically favorable conditions.
- 1 August 2017
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 528 (1-2) , 280-286
Raman imaging of cellular uptake and studies of silver nanoparticles effect in BJ human fibroblasts cell lines
- 1 August 2017
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 528 (1-2) , 280-286
Raman imaging of cellular uptake and studies of silver nanoparticles effect in BJ human fibroblasts cell lines
- 1 October 2016
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 96, 50-61
The effect of silver nanoparticles and silver ions on mammalian and plant cells in vitro
- 1 October 2016
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 96, 50-61
The effect of silver nanoparticles and silver ions on mammalian and plant cells in vitro
- 1 August 2016
- Published by Elsevier in Toxicology in Vitro
- Vol. 34, 246-256
The in vitro cytotoxicity of metal-complexes of porphyrin sensitizer intended for photodynamic therapy
- 1 August 2016
- Published by Elsevier in Toxicology in Vitro
- Vol. 34, 246-256
The in vitro cytotoxicity of metal-complexes of porphyrin sensitizer intended for photodynamic therapy
- 21 June 2016
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 74 (3) , 419-425
Effect of Porphyrin Sensitizer MgTPPS4 on Cytoskeletal System of HeLa Cell Line—Microscopic Study
Metalloporphyrins are an important group of sensitizers with a porphyrin skeleton. Their photophysical properties are significantly affected by the nature of the central ion. In this work, we focus on the mechanical properties of a cervix carcinoma cell line which underwent photodynamic treatment (PDT) with MgTPPS4 photosensitzer. Atomic force microscopy alongside confocal microscopy was used to quantify and qualify the structural characteristics before and after PDT. Cells before PDT showed a fine actin network and higher elasticity with the median of Young modulus 12.2 kPa. After PDT, the median of Young modulus was 13.4 kPa and a large redistribution in the actin network was observed.
- 21 June 2016
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 74 (3) , 419-425
Effect of Porphyrin Sensitizer MgTPPS4 on Cytoskeletal System of HeLa Cell Line—Microscopic Study
Metalloporphyrins are an important group of sensitizers with a porphyrin skeleton. Their photophysical properties are significantly affected by the nature of the central ion. In this work, we focus on the mechanical properties of a cervix carcinoma cell line which underwent photodynamic treatment (PDT) with MgTPPS4 photosensitzer. Atomic force microscopy alongside confocal microscopy was used to quantify and qualify the structural characteristics before and after PDT. Cells before PDT showed a fine actin network and higher elasticity with the median of Young modulus 12.2 kPa. After PDT, the median of Young modulus was 13.4 kPa and a large redistribution in the actin network was observed.
- 1 July 2015
- Vol. 35 (7) , 3943-51
Phthalocyanine-mediated Photodynamic Treatment of Tumoural and Non-tumoural cell lines.
This study deals with the use of cationic far-red absorbing photosensitizers (λ(max) ~740 nm) from the group of the phthalocyanines, in photodynamic therapy. The photosensitizers differed in their central atom, bearing either hydrogen, zinc or magnesium. These photosensitizers were tested in vitro on the tumour cell line HeLa (cervical cancer) and non-tumour cell line NIH3T3 (mouse fibroblast). The following tests were performed: measurement of reactive oxygen species production, viability testing, Comet assay and cell type detection (apoptotic, necrotic and living cells). The best results were achieved with zinc derivative at relatively low half-maximum inhibitory concentration (0.04 μM) and a total radiation dose of 15 J cm(-2).
- 1 July 2015
- Vol. 35 (7) , 3943-51
Phthalocyanine-mediated Photodynamic Treatment of Tumoural and Non-tumoural cell lines.
This study deals with the use of cationic far-red absorbing photosensitizers (λ(max) ~740 nm) from the group of the phthalocyanines, in photodynamic therapy. The photosensitizers differed in their central atom, bearing either hydrogen, zinc or magnesium. These photosensitizers were tested in vitro on the tumour cell line HeLa (cervical cancer) and non-tumour cell line NIH3T3 (mouse fibroblast). The following tests were performed: measurement of reactive oxygen species production, viability testing, Comet assay and cell type detection (apoptotic, necrotic and living cells). The best results were achieved with zinc derivative at relatively low half-maximum inhibitory concentration (0.04 μM) and a total radiation dose of 15 J cm(-2).